表紙:疼痛管理デバイスの世界市場:製品別、アプリケーション別、地域別の予測(2026年まで)- COVID-19の累積的影響
市場調査レポート
商品コード
1034553

疼痛管理デバイスの世界市場:製品別、アプリケーション別、地域別の予測(2026年まで)- COVID-19の累積的影響

Pain Management Devices Market Research Report by Product, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 186 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=115.72円
疼痛管理デバイスの世界市場:製品別、アプリケーション別、地域別の予測(2026年まで)- COVID-19の累積的影響
出版日: 2021年10月28日
発行: 360iResearch LLP
ページ情報: 英文 186 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の疼痛管理デバイスの市場規模は、2020年には54億9,178万米ドルとなり、2021年には62億9,908万米ドルに達し、その後はCAGR 15.03%で推移し、2026年には127億2,832万米ドルになると予想されています。

当レポートは、世界の疼痛管理デバイス市場について調査しており、市場の機会や課題、成長および抑制要因、COVID-19の累積的影響、製品・アプリケーション・地域別の市場分析、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象期間
  • 通貨と価格
  • 言語
  • 制限事項
  • 前提条件
  • 利害関係者

第2章 調査手法

  • 定義:調査目的
  • 決定:調査計画
  • 準備:調査機器
  • 収集:データソース
  • 分析:データの解釈
  • 策定:データ検証
  • 公開:調査レポート
  • 繰り返し:レポートの更新

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場の洞察

  • 市場力学
    • 成長要因
    • 抑制要因
    • 市場機会
    • 課題
  • COVID-19の累積的影響

第6章 製品別の疼痛管理デバイス市場

  • 鎮痛剤輸液ポンプ
    • 外部輸液ポンプ
    • 髄腔内輸液ポンプ
  • 電気刺激装置
    • TENS
  • 神経刺激
    • 深部脳刺激装置
    • 仙骨神経刺激装置
    • 脊髄刺激装置
  • 高周波アブレーション

第7章 アプリケーション別の疼痛管理デバイス市場

  • 顔面および片頭痛
  • 筋骨格系障害
  • 神経因性疼痛
  • 外傷

第8章 南北アメリカの疼痛管理デバイス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域の疼痛管理デバイス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第10章 欧州、中東・アフリカの疼痛管理デバイス市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 主要企業別市場シェア分析
  • 競合シナリオ
    • 合併・買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 評価、認知、拡大

第12章 企業プロファイル

  • Abbott
  • AVACEN medical
  • B Braun Melsungen AG
  • Baxter U.S.
  • Bioelectronics Corporation
  • Boston Scientific Corp.
  • CEFALY US
  • Colfax Corporation
  • DJO Global LLC
  • HealthmateForever USA
  • iTENS LLC
  • Johari Digital Healthcare Ltd.
  • Kimberly Clark Corporation
  • Medtronic Plc.
  • Multi Radiance Medical
  • NeuroMetrix Inc
  • Nevro Corp.
  • Omron Healthcare Inc.
  • Oska Wellness
  • Pain Care Labs
  • Pain management technologies Inc
  • Smiths Medical
  • Stimwave LLC
  • Stryker
  • Zynex International

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL PAIN MANAGEMENT DEVICES MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL PAIN MANAGEMENT DEVICES MARKET: MARKET DYNAMICS
  • FIGURE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2020 VS 2026 (%)
  • FIGURE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2020 VS 2026 (USD MILLION)
  • FIGURE 5. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2026
  • FIGURE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2026 (USD MILLION)
  • FIGURE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, 2018-2026 (USD MILLION)
  • FIGURE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL INFUSION PUMPS, 2018-2026 (USD MILLION)
  • FIGURE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL INFUSION PUMPS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATORS, 2018-2026 (USD MILLION)
  • FIGURE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATORS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TENS, 2018-2026 (USD MILLION)
  • FIGURE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TENS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROSTIMULATION, 2018-2026 (USD MILLION)
  • FIGURE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 18. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY SACRAL NEUROSTIMULATORS, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY SACRAL NEUROSTIMULATORS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 27. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 29. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY FACIAL & MIGRAINE, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY FACIAL & MIGRAINE, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL DISORDER, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRAUMA, 2018-2026 (USD MILLION)
  • FIGURE 38. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRAUMA, BY REGION, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 40. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 41. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 42. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 43. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 44. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 45. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 46. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 47. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 48. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 49. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 50. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 51. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 52. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 53. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 54. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 55. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 56. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 58. FRANCE PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 59. GERMANY PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 60. ITALY PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 61. NETHERLANDS PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 62. QATAR PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 63. RUSSIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 64. SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 65. SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 66. SPAIN PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 67. UNITED ARAB EMIRATES PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 68. UNITED KINGDOM PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • FIGURE 69. GLOBAL PAIN MANAGEMENT DEVICES MARKET: FPNV POSITIONING MATRIX
  • FIGURE 70. GLOBAL PAIN MANAGEMENT DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PAIN MANAGEMENT DEVICES MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL PAIN MANAGEMENT DEVICES MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRODUCT, 2018-2026 (USD MILLION)
  • TABLE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY EXTERNAL INFUSION PUMPS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL INFUSION PUMPS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATORS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TENS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROSTIMULATION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEEP BRAIN STIMULATORS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY SACRAL NEUROSTIMULATORS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY SPINAL CORD STIMULATORS, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
  • TABLE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY FACIAL & MIGRAINE, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL DISORDER, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 18. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 19. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRAUMA, BY REGION, 2018-2026 (USD MILLION)
  • TABLE 20. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 21. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 22. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 23. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 24. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 25. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 27. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 28. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 29. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 30. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 31. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 32. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 33. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 34. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 35. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 36. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 37. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 38. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 39. FRANCE PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 40. GERMANY PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 41. ITALY PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 42. NETHERLANDS PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 43. QATAR PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 44. RUSSIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 45. SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 46. SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 47. SPAIN PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 48. UNITED ARAB EMIRATES PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 49. UNITED KINGDOM PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2026 (USD MILLION)
  • TABLE 50. GLOBAL PAIN MANAGEMENT DEVICES MARKET: SCORES
  • TABLE 51. GLOBAL PAIN MANAGEMENT DEVICES MARKET: BUSINESS STRATEGY
  • TABLE 52. GLOBAL PAIN MANAGEMENT DEVICES MARKET: PRODUCT SATISFACTION
  • TABLE 53. GLOBAL PAIN MANAGEMENT DEVICES MARKET: RANKING
  • TABLE 54. GLOBAL PAIN MANAGEMENT DEVICES MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 55. GLOBAL PAIN MANAGEMENT DEVICES MARKET: MERGER & ACQUISITION
  • TABLE 56. GLOBAL PAIN MANAGEMENT DEVICES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 57. GLOBAL PAIN MANAGEMENT DEVICES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 58. GLOBAL PAIN MANAGEMENT DEVICES MARKET: INVESTMENT & FUNDING
  • TABLE 59. GLOBAL PAIN MANAGEMENT DEVICES MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 60. GLOBAL PAIN MANAGEMENT DEVICES MARKET: LICENSE & PRICING
目次
Product Code: MRR-ED54C46E8334

The Global Pain Management Devices Market size was estimated at USD 5,491.78 million in 2020 and expected to reach USD 6,299.08 million in 2021, at a CAGR 15.03% to reach USD 12,728.32 million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Pain Management Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

  • Based on Product, the market was studied across Analgesic Infusion Pumps, Electrical Stimulators, Neurostimulation, and Radiofrequency Ablation. The Analgesic Infusion Pumps is further studied across External Infusion Pumps and Intrathecal Infusion Pumps. The Electrical Stimulators is further studied across TENS. The Neurostimulation is further studied across Deep Brain Stimulators, Sacral Neurostimulators, and Spinal Cord Stimulators.
  • Based on Application, the market was studied across Cancer, Facial & migraine, Musculoskeletal disorder, Neuropathic pain, and Trauma.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pain Management Devices Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pain Management Devices Market, including Abbott, AVACEN medical, B Braun Melsungen AG, Baxter U.S., Bioelectronics Corporation, Boston Scientific Corp., CEFALY US, Colfax Corporation, DJO Global LLC, HealthmateForever USA, iTENS LLC, Johari Digital Healthcare Ltd., Kimberly Clark Corporation, Medtronic Plc., Multi Radiance Medical, NeuroMetrix Inc, Nevro Corp., Omron Healthcare Inc., Oska Wellness, Pain Care Labs, Pain management technologies Inc, Smiths Medical, Stimwave LLC, Stryker, and Zynex International.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Pain Management Devices Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pain Management Devices Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pain Management Devices Market?
  • 4. What is the competitive strategic window for opportunities in the Global Pain Management Devices Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Pain Management Devices Market?
  • 6. What is the market share of the leading vendors in the Global Pain Management Devices Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Pain Management Devices Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Define: Research Objective
  • 2.3. Determine: Research Design
  • 2.4. Prepare: Research Instrument
  • 2.5. Collect: Data Source
  • 2.6. Analyze: Data Interpretation
  • 2.7. Formulate: Data Verification
  • 2.8. Publish: Research Report
  • 2.9. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of musculoskeletal disorders
      • 5.1.1.2. Rising incidences of chronic diseases and lifestyle disorders
      • 5.1.1.3. Growing demand for long term pain management among geriatric population
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of pain specialists as well as pain clinics in low income economies
    • 5.1.3. Opportunities
      • 5.1.3.1. Improving healthcare infrastructure of the developing countries
      • 5.1.3.2. Decrease in consumption of pain medicines and preferences for quick relief devices
    • 5.1.4. Challenges
      • 5.1.4.1. High procedural and purchase cost of pain management devices
  • 5.2. Cumulative Impact of COVID-19

6. Pain Management Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Analgesic Infusion Pumps
    • 6.2.1. External Infusion Pumps
    • 6.2.2. Intrathecal Infusion Pumps
  • 6.3. Electrical Stimulators
    • 6.3.1. TENS
  • 6.4. Neurostimulation
    • 6.4.1. Deep Brain Stimulators
    • 6.4.2. Sacral Neurostimulators
    • 6.4.3. Spinal Cord Stimulators
  • 6.5. Radiofrequency Ablation

7. Pain Management Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Facial & migraine
  • 7.4. Musculoskeletal disorder
  • 7.5. Neuropathic pain
  • 7.6. Trauma

8. Americas Pain Management Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Pain Management Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Pain Management Devices Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Abbott
  • 12.2. AVACEN medical
  • 12.3. B Braun Melsungen AG
  • 12.4. Baxter U.S.
  • 12.5. Bioelectronics Corporation
  • 12.6. Boston Scientific Corp.
  • 12.7. CEFALY US
  • 12.8. Colfax Corporation
  • 12.9. DJO Global LLC
  • 12.10. HealthmateForever USA
  • 12.11. iTENS LLC
  • 12.12. Johari Digital Healthcare Ltd.
  • 12.13. Kimberly Clark Corporation
  • 12.14. Medtronic Plc.
  • 12.15. Multi Radiance Medical
  • 12.16. NeuroMetrix Inc
  • 12.17. Nevro Corp.
  • 12.18. Omron Healthcare Inc.
  • 12.19. Oska Wellness
  • 12.20. Pain Care Labs
  • 12.21. Pain management technologies Inc
  • 12.22. Smiths Medical
  • 12.23. Stimwave LLC
  • 12.24. Stryker
  • 12.25. Zynex International

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing